Walking a Fine Line: Safe and Effective Management of Type 2 Diabetes in Older Adults

Walking a Fine Line: Safe and Effective Management of Type 2 Diabetes in Older Adults

Wednesday, February 9, 2022
Webinar -- 12:00 PM ET


  • Review of Diabetes in Older Adults
  • Role of FRC Basal Insulin and GLP-1 RA in Older Adults
  • Management considerations for older adults in the community and LTCF
  • Questions and Answers


Program Director
Derek LeRoith, MD, PhD

Full Professor

Division of Endocrinology
Department of Medicine
Mount Sinai School of Medicine
Mount Sinai Hospital
New York, New York

Haley Phillippe, PharmD., BCPS, BCGP, FASCP

Associate Clinical Professor
Pharmacy Practice
Auburn University Harrison School of Pharmacy
Ambulatory Care Clinical Pharmacist
Family Medicine, Huntsville Campus
University of Alabama at Birmingham School of Medicine
Huntsville, Alabama

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES

Assistant Professor of Medicine
Diabetes Nurse Practitioner
Division of Endocrinology, Diabetes and Metabolism
Weill Cornell Medicine
New York, NY

Goal Statement
The goal of this activity is to improve the knowledge and competence of geriatricians, gerontological nurse practitioners, consultant and senior care pharmacists, and other HCPs regarding the management of older adults with diabetes, including those in a long-term care setting.

Target Audience
This program is intended for those HCPs who manage older patients with diabetes in both the outpatient and long-term care setting, including geriatricians, internal medicine physicians, advanced practice providers (nurse practitioners or physician assistants), and consultant pharmacists.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify patient specific-factors that should be considered when determining individualized glycemic goals for older adults with T2D.
  • Describe the efficacy and safety from clinical study results to support the use of FRC basal insulin and GLP-1 RA in appropriate patients.
  • Integrate FRC basal insulin and GLP-1 RA into the care of appropriate patients according to guideline recommendations and patient factors/preferences.
  • Detail important patient and drug considerations that can help ensure safe and effective T2D pharmacotherapy in older patients residing in LTCFs.

Learning Outcome:
As a result of participating in this webinar series providers will report an intent to change practice because of improved knowledge and competence regarding the management of older adults with diabetes. 



The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation:

The University of Cincinnati designates this webcast activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*The American Academy of Physician Assistants accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.


Nursing Continuing Education

This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), and Clinical Care Options.

Anthony J. Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

1.0 contact hour (which includes 1 hour of pharmacology credit) will be earned by learners who successfully complete this nursing continuing professional development activity.

You must participate in at least 90% of this activity and complete the evaluation form to receive nursing continuing professional development credit.

Continuing Pharmacy Education (CPE)

The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ASCP designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0203-9999-22-003-L01-P

Type of Activity: Application

You must participate in this activity in its entirety and complete the evaluation form to receive CPE credit. Partial credit will not be granted. The course should be posted to CPE Monitor within 60 days of evaluation completion.

Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies (commercial interest) within the last 24-months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education.

Disclosure will be made at the time of activity.